Royal Bank of Canada’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$152M Buy
3,155,080
+470,882
+18% +$22M 0.03% 492
2025
Q4
$130M Sell
2,684,198
-592,056
-18% -$29.3M 0.02% 554
2025
Q3
$155M Buy
3,276,254
+38,453
+1% +$1.86M 0.03% 514
2025
Q2
$156M Buy
3,237,801
+805,100
+33% +$41.1M 0.03% 468
2025
Q1
$135M Buy
2,432,701
+40,213
+2% +$2.18M 0.03% 453
2024
Q4
$115M Sell
2,392,488
-51,511
-2% -$2.62M 0.02% 526
2024
Q3
$141M Sell
2,443,999
-62,609
-2% -$3.38M 0.03% 454
2024
Q2
$122M Buy
2,506,608
+246,544
+11% +$11.9M 0.03% 462
2024
Q1
$110M Buy
2,260,064
+245,937
+12% +$12M 0.03% 490
2023
Q4
$100M Sell
2,014,127
-88,986
-4% -$4.35M 0.02% 525
2023
Q3
$113M Sell
2,103,113
-22,387
-1% -$1.19M 0.03% 433
2023
Q2
$115M Buy
2,125,500
+59,424
+3% +$3.2M 0.03% 444
2023
Q1
$112M Buy
2,066,076
+347,944
+20% +$16.9M 0.03% 433
2022
Q4
$83.2M Sell
1,718,132
-63,742
-4% -$2.8M 0.02% 515
2022
Q3
$67.7M Sell
1,781,874
-53,468
-3% -$2.38M 0.02% 545
2022
Q2
$91.8M Sell
1,835,342
-5,077
-0.3% -$269K 0.03% 454
2022
Q1
$94.5M Buy
1,840,419
+213,587
+13% +$11M 0.02% 518
2021
Q4
$81.5M Buy
1,626,832
+3,314
+0.2% +$164K 0.02% 601
2021
Q3
$78.3M Buy
1,623,518
+71,060
+5% +$3.61M 0.02% 580
2021
Q2
$81.8M Buy
1,552,458
+58,214
+4% +$3.04M 0.02% 555
2021
Q1
$73.9M Sell
1,494,244
-823
-0.1% -$39.5K 0.02% 552
2020
Q4
$72.6M Buy
1,495,067
+8,023
+0.5% +$396K 0.02% 558
2020
Q3
$74.6M Sell
1,487,044
-14,235
-0.9% -$733K 0.03% 477
2020
Q2
$76.6M Buy
1,501,279
+61,199
+4% +$2.97M 0.03% 436
2020
Q1
$63M Sell
1,440,080
-23,636
-2% -$1.13M 0.03% 432
2019
Q4
$73.5M Buy
1,463,716
+64,690
+5% +$3.03M 0.03% 478
2019
Q3
$64.8M Sell
1,399,026
-26,387
-2% -$1.14M 0.03% 501
2019
Q2
$61.7M Buy
1,425,413
+157,222
+12% +$6.69M 0.02% 510
2019
Q1
$56.2M Buy
1,268,191
+16,536
+1% +$708K 0.02% 523
2018
Q4
$54.3M Buy
1,251,655
+22,430
+2% +$989K 0.03% 493
2018
Q3
$54.9M Sell
1,229,225
-369,101
-23% -$15.8M 0.02% 555
2018
Q2
$64M Sell
1,598,326
-5,500
-0.3% -$217K 0.03% 466
2018
Q1
$64.3M Buy
1,603,826
+94,224
+6% +$3.92M 0.03% 479
2017
Q4
$64.9M Sell
1,509,602
-214,728
-12% -$9.9M 0.03% 486
2017
Q3
$85.9M Sell
1,724,330
-160,568
-9% -$7.77M 0.04% 351
2017
Q2
$90.3M Sell
1,884,898
-82,888
-4% -$3.96M 0.05% 316
2017
Q1
$89M Sell
1,967,786
-116,164
-6% -$4.93M 0.05% 308
2016
Q4
$84.3M Sell
2,083,950
-600,662
-22% -$23.7M 0.05% 340
2016
Q3
$103M Buy
2,684,612
+325,348
+14% +$13.1M 0.06% 277
2016
Q2
$98.7M Buy
2,359,264
+328,936
+16% +$13.5M 0.06% 263
2016
Q1
$81.5M Buy
2,030,328
+134,423
+7% +$5.4M 0.05% 302
2015
Q4
$80.9M Buy
1,895,905
+374,681
+25% +$17.2M 0.05% 287
2015
Q3
$72.2M Sell
1,521,224
-17,891
-1% -$911K 0.05% 240
2015
Q2
$76.2M Buy
1,539,115
+43,722
+3% +$2.22M 0.05% 251
2015
Q1
$73.9M Buy
1,495,393
+268,012
+22% +$12.8M 0.05% 274
2014
Q4
$56M Buy
1,227,381
+52,090
+4% +$2.53M 0.04% 379
2014
Q3
$66.3M Buy
1,175,291
+94,423
+9% +$5.07M 0.05% 293
2014
Q2
$57.5M Buy
1,080,868
+65,787
+6% +$3.49M 0.04% 337
2014
Q1
$53.1M Sell
1,015,081
-28,149
-3% -$1.42M 0.04% 353
2013
Q4
$55.9M Buy
1,043,230
+86,712
+9% +$4.47M 0.04% 342
2013
Q3
$48.4M Buy
956,518
+211,183
+28% +$10.7M 0.04% 362
2013
Q2
$38.4M Buy
+745,335
New +$39.7M 0.03% 419

Other funds holding SNY

Royal Bank of Canada's SNY Position: Q1 2026 in Review

Royal Bank of Canada increased its Sanofi (SNY) stake by 18% in Q1 2026, buying an estimated $22M and bringing the position to 3,155,080 shares worth $152M. The position accounts for 0.03% of the portfolio, ranked #492.

Royal Bank of Canada first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $156M in Q2 2025. 741 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Royal Bank of Canada held 3,155,080 shares of Sanofi worth $152M as of Q1 2026.
  • Royal Bank of Canada bought 470,882 Sanofi shares in Q1 2026, an estimated $22M.
  • Sanofi made up 0.03% of Royal Bank of Canada's portfolio in Q1 2026, its #492 holding.
  • Royal Bank of Canada first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Sanofi position peaked at $156M in Q2 2025.
  • 741 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.